Fidelity Investments’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
VCM
NTCM
Fidelity Investments's IRMD Position: Q1 2026 in Review
Fidelity Investments increased its iRadimed (IRMD) stake by 0.51% in Q1 2026, buying an estimated $33.7K and bringing the position to 67,069 shares worth $6.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2217.
Fidelity Investments first reported a position in IRMD in Q1 2022 and has held it in 17 quarters since. The position peaked at $6.49M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- Fidelity Investments held 67,069 shares of iRadimed worth $6.46M as of Q1 2026.
- Fidelity Investments bought 337 iRadimed shares in Q1 2026, an estimated $33.7K.
- iRadimed made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2217 holding.
- Fidelity Investments first reported a position in iRadimed in Q1 2022 and has held it in 17 quarters since.
- Fidelity Investments's iRadimed position peaked at $6.49M in Q4 2025.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.